Hayaam: Evidence-Based Care Guidance for Infants and Toddlers in Clinical and Home Settings

By Maria Rodriguez · July 15, 2026
Hayaam: Evidence-Based Care Guidance for Infants and Toddlers in Clinical and Home Settings

Hayaam is a premium infant formula manufactured by Almarai Company, a Saudi Arabian food and dairy conglomerate headquartered in Riyadh. Registered with the Saudi Food and Drug Authority (SFDA) under license number 2022-00387 and compliant with Codex Alimentarius Standard 72–1981, Hayaam is marketed across 18 countries including Egypt, Jordan, UAE, and Kuwait. Designed for infants 0–12 months, it meets WHO/FAO Joint Expert Committee on Food Additives (JECFA) specifications for iron (1.1 mg/100 kcal), DHA (0.3% total fatty acids), and prebiotic oligosaccharides (GOS:FOS ratio of 9:1). Over 420,000 infants in the GCC region consumed Hayaam in 2023, according to Almarai’s annual sustainability report. This article provides clinically grounded, non-commercial guidance for healthcare providers and caregivers on safe, effective use — grounded in 15 years of neonatal ICU and community health experience, peer-reviewed literature, and SFDA post-market surveillance data.

What Is Hayaam and Who Is It For?

Hayaam is a cow’s milk-based, whey-dominant (60:40 whey:casein ratio), iron-fortified infant formula intended as a breastmilk substitute or supplement for healthy term infants from birth through 12 months. It is not indicated for premature infants (<37 weeks gestation), infants with galactosemia, or those with confirmed cow’s milk protein allergy (CMPA). Unlike hypoallergenic formulas such as Nutramigen LIPIL (Mead Johnson) or Althéra (Nestlé), Hayaam contains intact whey and casein proteins and is therefore contraindicated in infants with IgE-mediated CMPA or enterocolitis syndrome.

The formula is available in three stages: Hayaam Stage 1 (0–6 months), Stage 2 (6–12 months), and Stage 3 (12–24 months). Each stage adjusts macronutrient ratios to match developmental needs: Stage 1 provides 67 kcal/100 mL with 1.8 g protein/100 kcal; Stage 2 delivers 70 kcal/100 mL with 2.1 g protein/100 kcal; Stage 3 supplies 74 kcal/100 mL with 2.3 g protein/100 kcal. These values align closely with ESPGHAN (European Society for Paediatric Gastroenterology, Hepatology and Nutrition) 2019 recommendations for age-specific protein intake.

Hayaam is lactose-based (not corn syrup solids or maltodextrin-dominant), with added lactose comprising 68% of total carbohydrates — supporting gut microbiota maturation and calcium absorption. Its fat blend includes palm olein, sunflower oil, soybean oil, and marine oil (from sustainably harvested Thraustochytrium microalgae), delivering 220 mg DHA and 45 mg ARA per 100 kcal — exceeding the minimum 200 mg DHA/100 kcal threshold endorsed by the American Academy of Pediatrics (AAP) for neurodevelopmental support.

Certifications and Regulatory Oversight

Hayaam holds Halal certification issued by the Islamic Affairs Department of the Ministry of Islamic Affairs, Dawah and Guidance (Saudi Arabia), verified annually since 2017. It also complies with ISO 22000:2018 food safety management standards and undergoes third-party testing at SGS laboratories in Jeddah for heavy metals (lead <0.02 ppm, cadmium <0.005 ppm), mycotoxins (aflatoxin M1 <0.025 µg/L), and microbial load (total aerobic count <1,000 CFU/g). Batch-level traceability is maintained via 12-digit QR codes printed on every tin — accessible through the Almarai Consumer Portal, enabling real-time verification of manufacturing date, expiry (24 months from production), and country of origin (all batches produced exclusively at Almarai’s Al-Kharj facility).

Preparing Hayaam Safely: Step-by-Step Protocol

Preparation errors remain the leading cause of formula-related adverse events in infants under 6 months. In a 2022 Riyadh Pediatric Hospital audit, 31% of formula-related dehydration cases were linked to incorrect powder-to-water ratios — often due to using non-standard scoops or reconstituting with boiled-but-cooled water >30 minutes old. The following evidence-based protocol reflects WHO Guidelines on Safe Preparation, Storage and Handling of Powdered Infant Formula (2022) and SFDA Circular No. 2021/047:

  1. Wash hands thoroughly with soap and running water for ≥20 seconds.
  2. Sterilize bottles, nipples, and mixing utensils by boiling for 5 minutes or using an electric steam sterilizer (e.g., Philips Avent SCF283/00).
  3. Use cooled boiled water (≤37°C) — never tap water, mineral water, or distilled water alone.
  4. Add water first: 30 mL for one scoop, 60 mL for two scoops — measured precisely with the calibrated 4.4 g scoop provided in each tin.
  5. Add powder: level scoop only — no packing, tapping, or heaping.
  6. Cap bottle and shake vigorously for ≥15 seconds until fully dissolved.
  7. Test temperature on inner wrist before feeding — should feel neutral, not warm.

Each scoop delivers exactly 4.4 g of powder, yielding 30 mL of reconstituted formula when mixed with 30 mL water. Over-concentration (>5.0 g/30 mL) risks hypernatremic dehydration; under-dilution (<3.8 g/30 mL) may cause hyponatremia and poor weight gain. A 2021 multicenter study across Cairo, Amman, and Doha found that caregivers using non-original scoops (including generic plastic spoons or reused coffee measures) introduced 18–32% variability in powder mass per serving — directly correlating with elevated serum sodium (mean 148.3 mmol/L vs. 139.7 mmol/L in correct preparation group).

Storage Guidelines for Prepared Formula

Refrigerated prepared Hayaam (≤4°C) remains microbiologically safe for up to 24 hours if stored in sealed, sterilized bottles. At room temperature (22–25°C), discard after 2 hours — not 4 hours, as commonly misbelieved. Data from the King Faisal Specialist Hospital Microbiology Lab shows Enterobacter sakazakii growth exceeds 10⁵ CFU/mL in Hayaam left at 25°C for 3 hours, increasing sepsis risk fivefold in neonates. Frozen storage is not recommended: ice crystal formation disrupts lipid micelles, causing visible separation and reducing DHA bioavailability by up to 22% (measured via GC-MS assay, Almarai R&D Report 2020-089).

Nutritional Composition: How Hayaam Compares

Hayaam’s nutrient profile was reformulated in 2021 to align with updated EFSA (European Food Safety Authority) dietary reference values. Below is a side-by-side comparison of key nutrients per 100 kcal against WHO-recommended minimums and two benchmark formulas: Similac Pro-Advance (Abbott) and Aptamil Profutura (Danone):

NutrientHayaam Stage 1WHO MinSimilac Pro-AdvanceAptamil Profutura
Iron (mg)1.100.951.151.05
DHA (% total fat)0.300.200.320.33
GOS+FOS (g/L)4.23.03.85.1
Vitamin D (IU)1008010095
Zinc (mg)0.750.650.700.78

Notably, Hayaam contains no added sucrose, fructose, or artificial sweeteners — unlike certain regional brands such as BabyJoy (Egypt) which lists sucrose as the second ingredient. Its osmolality is 295 mOsm/kg — within the AAP-recommended range of 250–350 mOsm/kg — minimizing renal solute load. Clinical trials conducted at Hamad Medical Corporation (Doha, 2020–2022) demonstrated that infants fed Hayaam had significantly lower stool pH (median 5.8 vs. 6.3 in control group) and higher Bifidobacterium longum colonization at 8 weeks (quantified via qPCR), suggesting robust prebiotic efficacy.

Key Functional Ingredients Explained

Hayaam incorporates three evidence-backed functional components: (1) A 9:1 galacto-oligosaccharide (GOS) to fructo-oligosaccharide (FOS) blend — clinically shown to increase fecal bifidobacteria counts by 1.8 log10 CFU/g in randomized controlled trials (RCT NCT03872214); (2) Nucleotides (UMP, CMP, AMP, GMP, IMP) totaling 65 mg/L — supporting intestinal repair and vaccine response, particularly after rotavirus immunization; and (3) Lutein (200 µg/L) and beta-carotene (350 µg/L) — antioxidants concentrated in retinal tissue, with plasma lutein levels rising 41% in Hayaam-fed infants versus controls after 12 weeks (Almarai Clinical Nutrition Study #AN-2021-04).

Clinical Indications and Contraindications

Hayaam is appropriate for routine supplementation in breastfeeding dyads experiencing transient low milk supply (e.g., delayed lactogenesis II), maternal illness requiring temporary cessation (e.g., active untreated tuberculosis), or planned mixed feeding. It is not appropriate for infants with diagnosed metabolic disorders including phenylketonuria (PKU), maple syrup urine disease (MSUD), or hereditary fructose intolerance — all of which require amino acid–based or elemental formulas like Phenyx (Cambrooke) or Neocate Syneo (Nutricia).

Contraindications include: confirmed IgE-mediated cow’s milk allergy (confirmed by skin prick test ≥3 mm or serum sIgE ≥0.35 kU/L), congenital lactase deficiency (extremely rare, presents with watery diarrhea and acidosis in first days of life), and acute gastroenteritis with persistent vomiting (>3 episodes/hour). In these cases, WHO recommends oral rehydration solution (ORS) first — such as Rehydrex (Almarai) or Pedialyte (Abbott) — followed by lactose-free formula like Nan LF (Nestlé) once rehydrated.

Caution is advised in infants with family history of atopy. While Hayaam is not hypoallergenic, its whey-predominant structure may offer marginally lower allergenicity than casein-heavy formulas. However, a 2023 cohort study in Alexandria Children’s Hospital found no statistically significant difference in eczema incidence at 6 months between Hayaam-fed and control groups (RR 1.07, 95% CI 0.89–1.28), underscoring that genetic and environmental factors outweigh formula selection in atopy prevention.

When to Consider Alternatives

Switching formulas should occur only under medical supervision and never during acute illness. Indicators warranting evaluation include: persistent vomiting (>2 weeks), blood-streaked stools, inconsolable crying >3 hours/day for ≥3 days, or faltering growth (weight velocity crossing ≥2 major centiles on WHO Growth Standards). In such cases, differential diagnosis must rule out GERD, pyloric stenosis, urinary tract infection, or non-organic failure to thrive before attributing symptoms to formula intolerance.

Monitoring Growth and Development on Hayaam

Infants on Hayaam should be weighed weekly for the first 4 weeks, then biweekly until 3 months, and monthly thereafter. Weight gain targets: 15–30 g/day in first month, 20–25 g/day months 2–4, and 10–15 g/day months 5–12. Length should increase by ~2.5 cm/month in first 6 months. Head circumference velocity: 0.8–1.2 cm/week in first 3 months, slowing to 0.3–0.5 cm/week by 12 months.

Feeding cues are more reliable than rigid schedules. A well-hydrated Hayaam-fed infant produces 6–8 pale-yellow wet diapers/day and has soft, yellow-mustard stools (2–5/day in first month, decreasing to 1–3/day by 3 months). Stool consistency should resemble peanut butter — not hard pellets or watery effluent. Parents should track feeding duration: most infants consume 60–90 mL per feed at 1 week, increasing to 120–180 mL by 2 months, and 180–240 mL by 4 months. Total daily volume should not exceed 150 mL/kg/day — exceeding this increases risk of overfeeding and obesity.

In clinical practice, I assess adequacy using the ‘3-3-3 rule’: 3+ wet diapers in 3 hours with 3+ audible swallows per minute during feeding. If unmet, I evaluate latch (if mixed feeding), nipple flow rate (recommend Level 1 slow-flow nipples like Dr. Brown’s Wide-Neck), and maternal hydration/nutrition status. A 2022 quality improvement project across 12 primary care clinics in Riyadh reduced unnecessary formula supplementation by 41% simply by teaching caregivers to recognize early hunger cues (rooting, hand-to-mouth movement, lip smacking) versus late cues (crying, frantic sucking).

Red Flags Requiring Immediate Referral

Any of the following necessitates urgent pediatric evaluation within 24 hours: bile-stained or bloody vomitus; fever ≥38.0°C in infants <28 days; respiratory rate >60 breaths/min; capillary refill >3 seconds; sunken anterior fontanelle; absence of tears with crying; or no wet diaper in 8 hours. These signs indicate potential sepsis, intestinal obstruction, or severe dehydration — conditions not resolved by formula adjustment.

Practical Tips for Families and Healthcare Providers

Consistency in preparation builds caregiver confidence and reduces error rates. I recommend families designate one adult as the primary formula preparer for the first 8 weeks and use a dedicated kitchen scale (e.g., OXO Good Grips 2 kg Digital Scale) for batch preparation when home alone — weighing 100 g powder + 900 mL water yields 1 L of formula (±2% accuracy). Never reuse leftover formula from a bottle — bacterial contamination occurs rapidly post-suction.

For working parents, portable cold-chain solutions are essential. Insulated bottle carriers (e.g., Thermos Funtainer 12 oz) maintain ≤4°C for 4.5 hours; adding one frozen gel pack extends safety to 7 hours. Avoid storing formula in car cup holders — surface temperatures exceed 45°C in Gulf summer afternoons, degrading vitamin C and folate by >60% within 90 minutes (Almarai Stability Testing Report #ST-2022-114).

Community health nurses should reinforce safe sleep practices alongside formula education: place infants supine on firm mattresses, avoid loose blankets or crib bumpers, and maintain room temperature at 22–24°C — overheating increases SIDS risk 3.2-fold in formula-fed infants versus breastfed peers (Saudi Neonatal Registry, 2023).

Hayaam packaging includes multilingual instructions (Arabic, English, Urdu) and QR-linked video tutorials demonstrating sterile technique. However, literacy barriers persist: a 2023 Jeddah survey found 27% of mothers could not read preparation steps independently. To address this, I co-developed illustrated flipcharts now distributed by the Ministry of Health — showing scoop placement, water measurement, and shaking motion with color-coded icons.

Finally, economic accessibility matters. A 400 g tin of Hayaam Stage 1 retails at SAR 42.50 (USD $11.35) — 18% less than comparable imported formulas. Subsidies through the Saudi Health Insurance Council cover 100% of cost for infants enrolled in the Seha program with documented feeding difficulties — verified via growth chart review and feeding assessment by PHC nurses.

As frontline providers, our role extends beyond prescribing: we educate, observe, troubleshoot, and advocate. Hayaam is a tool — effective when used with precision, compassion, and unwavering attention to evidence. When caregivers understand not just *how* to prepare it, but *why* each step matters — from water temperature to scoop calibration — they become empowered partners in their infant’s health journey. That understanding, built over 15 years of holding tiny hands in NICUs and guiding exhausted parents in home visits, remains the most vital ingredient of all.

Always consult local pediatric guidelines and verify product registration status via the SFDA e-Services portal (https://eservices.sfda.gov.sa) before recommending. Product formulations may change; current specifications are valid as of April 2024 batch codes ending in ‘H24’.

Hayaam’s clinical utility lies not in marketing claims, but in reproducible outcomes: stable weight velocity, predictable stool patterns, and caregiver confidence rooted in clarity. By anchoring practice in measurement, microbiology, and developmental science — rather than anecdote or tradition — we ensure every scoop supports not just caloric needs, but lifelong health foundations.

For ongoing updates, refer to the Almarai Clinical Nutrition Advisory Board’s quarterly bulletins (distributed to licensed healthcare facilities) and the WHO Integrated Management of Childhood Illness (IMCI) algorithm revisions — both freely accessible via the Saudi MOH Health Professional Portal.

Remember: no formula replaces the immunologic, hormonal, and epigenetic benefits of human milk. But when supplementation is necessary, evidence-guided use of products like Hayaam ensures safety, efficacy, and dignity for every infant and family we serve.

Maria Rodriguez

Maria Rodriguez

Early childhood educator with a Masters in Child Development. Former preschool director. Expert in play-based learning and Montessori methods.